Blanco Jorge C G, Pletneva Lioubov M, Oue Raymonde O, Patel Mira C, Boukhvalova Marina S
Sigmovir Biosystems Inc., 9610 Medical Center Drive, Suite 100, Rockville, MD 20850, United States.
Sigmovir Biosystems Inc., 9610 Medical Center Drive, Suite 100, Rockville, MD 20850, United States.
Vaccine. 2015 Oct 5;33(41):5371-5379. doi: 10.1016/j.vaccine.2015.08.071. Epub 2015 Aug 31.
Respiratory Syncytial Virus (RSV) is the leading cause of pneumonia and bronchiolitis in infants, resulting in significant morbidity and mortality worldwide. There is currently no RSV vaccine. Although maternal serum antibodies against RSV are efficiently transferred through placenta protecting human infants from RSV-induced disease, this protection is short-lived and the methods for extending and augmenting protection are not known. The objective of this study was to develop an animal model of maternal RSV vaccination using the Sigmodon hispidus cotton rat. Naïve or RSV-primed female cotton rats were inoculated with live RSV and set in breeding pairs. Antibody transfer to the litters was quantified and the offspring were challenged with RSV at different ages for analysis of protection against viral replication and lung inflammation. There was a strong correlation between RSV-neutralizing antibody (NA) titers in cotton rat mothers and their pups, which also correlated with protection of litters against virus challenge. Passive protection was short-lived and strongly reduced in animals at 4 weeks after birth. Protection of litters was significantly enhanced by inoculating mothers parenterally with live RSV and inversely correlated with the expression of lung cytokines and pathology. Importantly, vaccination and boosting of naïve mothers with the live RSV produced the highest levels of NAs. We conclude that maternal vaccination against RSV in the cotton rat can be used to define vaccine preparations that could improve preexistent immunity and induce subsequent transfer of efficient immunity to infants.
呼吸道合胞病毒(RSV)是导致婴儿肺炎和细支气管炎的主要原因,在全球范围内造成了严重的发病率和死亡率。目前尚无RSV疫苗。尽管母体血清中针对RSV的抗体可通过胎盘有效转移,保护人类婴儿免受RSV引发的疾病,但这种保护是短暂的,且延长和增强保护的方法尚不清楚。本研究的目的是利用棉鼠建立母体RSV疫苗接种的动物模型。将未接触过RSV或已接触过RSV的雌性棉鼠接种活RSV,然后配对繁殖。对幼崽的抗体转移进行定量,并在不同年龄对后代进行RSV攻击,以分析其对病毒复制和肺部炎症的保护作用。棉鼠母亲及其幼崽的RSV中和抗体(NA)滴度之间存在很强的相关性,这也与幼崽对病毒攻击的保护作用相关。被动保护作用短暂,在出生后4周时动物的被动保护作用大幅降低。通过对母亲进行皮下接种活RSV,可显著增强幼崽的保护作用,且与肺细胞因子的表达和病理变化呈负相关。重要的是,用活RSV对未接触过RSV的母亲进行疫苗接种和加强免疫可产生最高水平的NA。我们得出结论,棉鼠母体RSV疫苗接种可用于确定能够改善先天免疫并诱导随后向婴儿有效转移免疫力的疫苗制剂。